A bioinspired capsule can pump drugs directly into the walls of the GI tract
The needle-free device could be used to deliver insulin, antibodies, RNA, or other large molecules.
The needle-free device could be used to deliver insulin, antibodies, RNA, or other large molecules.
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
MD/PhD student Sayo Eweje seeks to develop new technologies for delivering RNA and protein therapies directly to the body’s cells.
These zinc-air batteries, smaller than a grain of sand, could help miniscule robots sense and respond to their environment.
Propelled by MIT mentors and colleagues, two Kavanaugh Fellows will spend a year getting their innovative technologies ready for the market.
A microneedle patch that delivers immune-regulating molecules can teach T cells not to attack hair follicles, helping hair to regrow.
New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.
Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.
Award honors “scientists who have made a transformational contribution toward the improvement of human health.”
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Cancer nanomedicine was on display at the 2023 White House Demo Day.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.
Core-shell structures made of hydrogel could enable more efficient uptake in the body.
The fibers could help with testing treatments for nerve-related pain.